The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Cartesian Therapeutics Inc shares valued at $41,374 were sold by Kurtoglu Metin on Jan 06 ’25. At $16.83 per share, Kurtoglu Metin sold 2,458 shares. The insider’s holdings dropped to 62,258 shares worth approximately $1.05 million following the completion of this transaction.
Also, Kurtoglu Metin sold 2,417 shares, netting a total of over 40,417 in proceeds. Following the sale of shares at $16.72 each, the insider now holds 64,716 shares.
Before that, Miljkovic Milos had sold 948 shares from its account. In a trade valued at $15,957, the Chief Medical Officer traded Cartesian Therapeutics Inc shares for $16.83 each. Upon closing the transaction, the insider’s holdings decreased to 948 shares, worth approximately $0.6 million.
As published in their initiating research note from BTIG Research on December 19, 2024, Cartesian Therapeutics Inc [RNAC] has been a Buy and the price target has been revised to $42. Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in early August. As of July 02, 2024, Oppenheimer has decreased its “an Outperform” rating to a “Perform” for RNAC. Earlier on June 04, 2024, Oppenheimer initiated its rating. Their recommendation was “an Outperform” for RNAC stock.
Analyzing RNAC Stock Performance
During the last five days, there has been a drop of approximately -5.53%. Over the course of the year, Cartesian Therapeutics Inc shares have dropped approximately -5.53%. Shares of the company reached a 52-week high of $18.30 on 01/02/25 and a 52-week low of $16.40 on 01/06/25. A 50-day SMA is recorded $19.36, while a 200-day SMA reached $19.82. Nevertheless, trading volume fell to 0.14 million shares from 0.11 million shares the previous day.
Support And Resistance Levels for Cartesian Therapeutics Inc (RNAC)
According to the 24-hour chart, there is a support level at 16.59, which, if violated, would cause prices to drop to 16.26. In the upper region, resistance lies at 17.25. The next price resistance is at 17.59. RSI (Relative Strength Index) is 41.61 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.97, which suggests the price will decrease in the coming days. Percent R is at 86.65%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
